Zhuang Aobo, Lu Weiqi, Fang Yuan, Ma Lijie, Xu Jing, Wang Jiongyuan, Tong Hanxing, Zhang Yong
Department of General Surgery, South Hospital of the Zhongshan Hospital/Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Front Oncol. 2022 Apr 11;12:856754. doi: 10.3389/fonc.2022.856754. eCollection 2022.
This study aimed to explore the prognostic factors for first local recurrent retroperitoneal soft tissue sarcoma (FLR-RPS) and construct predictive nomograms in the Asian population.
In a single Asian sarcoma center, data of patients with FLR-RPS were retrospectively analyzed from January 2011 to September 2020. We developed and internally validated prognostic factors determined by the Cox regression model, as well as nomograms for predicting recurrence-free survival (RFS) and overall survival (OS). The concordance index and calibration curve were used to determine the nomogram's discriminative and predictive ability.
With 169 patients, the median follow-up duration was 48 months and the 5-year OS rate was 60.9% (95% confidence interval (CI), 51.9%-69.9%). OS was correlated with chemotherapy at the time of initial surgery and tumor grading. The 5-year cumulative local recurrence rate and distant metastasis rate were 75.9% (95% CI, 67.5%-84.3%) and 10.1% (95% CI, 4.2%-16.0%), respectively, and the length of the disease-free interval following the primary operation was associated with disease recurrence. The 6-year OS and cumulative recurrence rate after surgery in our cohort were comparable with those in the TARPSWG cohort, but the proportion of local recurrence was higher (80.4% vs. 59.0%), and distant metastasis was less common (10.1% vs. 14.6%). In this study, two nomogram prediction models were established, which could predict the 1-, 2-, and 5-year OS and RFS, and the concordance indices were 0.74 and 0.70, respectively. The calibration plots were excellent.
For the FLR-RPS patients, some can still achieve an ideal prognosis. The treatment of FLR-RPS in Asian populations can be aided by the predictive model established in this study.
本研究旨在探讨亚洲人群中首次局部复发的腹膜后软组织肉瘤(FLR-RPS)的预后因素,并构建预测列线图。
在一个单一的亚洲肉瘤中心,对2011年1月至2020年9月期间FLR-RPS患者的数据进行回顾性分析。我们通过Cox回归模型确定并内部验证了预后因素,以及用于预测无复发生存期(RFS)和总生存期(OS)的列线图。一致性指数和校准曲线用于确定列线图的辨别能力和预测能力。
169例患者的中位随访时间为48个月,5年总生存率为60.9%(95%置信区间(CI),51.9%-69.9%)。总生存期与初次手术时的化疗及肿瘤分级相关。5年累积局部复发率和远处转移率分别为75.9%(95%CI,67.5%-84.3%)和10.1%(95%CI,4.2%-16.0%),初次手术后无病间期的长度与疾病复发相关。我们队列中手术后的6年总生存率和累积复发率与TARPSWG队列中的相当,但局部复发比例更高(80.4%对59.0%),远处转移较少见(10.1%对14.6%)。在本研究中,建立了两个列线图预测模型,可预测1年、2年和5年的总生存期和无复发生存期,一致性指数分别为0.74和0.70。校准图效果良好。
对于FLR-RPS患者,部分患者仍可获得理想预后。本研究建立的预测模型可为亚洲人群中FLR-RPS的治疗提供帮助。